LONDON, September 5 /PRNewswire/ -- Most government and learning disability organisations are still failing to give the UK's 1.5 million people with learning disabilities (LD) a voice and a say in how their services are 'personalised'.

UK Government's policy is now that people with LD should receive personalised social care. Multimedia provides a proven tool to help people with LD achieve this. But the technology seems too challenging for the majority of social carers, says Andy Minnion, director of the Rix Centre.

EAST SYRACUSE, New York, September 5 /PRNewswire/ --

- Company Climbs Three Spots in Overall Ranking of Technical Strength

PPC, a global manufacturer of connector technology for the cable TV, satellite, wireless and telecommunications industries, rose to the number two spot for industry impact among the top 35 most innovative companies in the United States, according to the Industrial Components and Fixtures Patent Scorecard published August 19, 2008, in the Wall Street Journal.

VIENNA, Austria and FLORENCE, Italy, September 5 /PRNewswire/ --

- Mikhail Gorbachev Will Present the Prize at the WOMEN'S WORLD AWARDS 2008

Picture is available via EPA (European Pressphoto Agency) and can be downloaded free of charge at: http://www.presseportal.de/pm/60279/?keygroup=bild

The WORLD AWARDS Association, presided by Nobel Peace Prize Laureate Mikhail Gorbachev, today announced the first WOMEN'S WORLD AWARDS winner for 2008: Ingrid Betancourt, 46, the former Columbian presidential candidate, kidnapped in 2002 by the Revolutionary Armed Forces of Columbia (FARC) and held captive in the Columbian jungle for six and a half years, will receive the WOMAN OF THE YEAR AWARD 2008.

COPENHAGEN, Denmark, September 5 /PRNewswire/ --

- Update on the Regulatory Strategy for Belinostat in PTCL

COPENHAGEN, Denmark, September 5 /PRNewswire/ --

TopoTarget A/S (OMX: TOPO) announced that a positive reply from the FDA was received on a Special Protocol Assessment (SPA) for a phase III trial for belinostat in PTCL (Peripheral T-Celle Lymphoma). This pivotal trial is to enrol approximately 120 patients and is to begin in Q4 2008. In June Fast Track designation was granted for the development of belinostat in this indication which supports TopoTarget's rapid market entry strategy. There is currently no standard therapy approved for PTCL.

HITCHIN, England, September 5 /PRNewswire/ -- The 'Impact of Flu in the Workplace' conference is bringing together, for the first time, leading experts from occupational health, medicine and the NHS to review the value of flu vaccination undertaken by employers as well as providing an update on related issue such as the overall risk of pandemic flu and its impact to the UK workforce.

ROSEAU, Commonwealth of Dominica, September 5 /PRNewswire/ -- Neuftec Limited, the proprietor of a new, highly successful technology producing greener fuel (the original nano-particulate cerium oxide fuel catalyst previously sold by Oxonica as Envirox(TM)), announced today that the High Court successfully upheld Neuftec's license rights in the face of a claim brought by Oxonica Energy Limited. Oxonica Energy is a wholly owned subsidiary of Oxonica PLC, the Aim-listed Oxford University spin-out, chaired by former Dragon's Den TV star Richard Farleigh. Since 2002 Envirox(TM) has represented approximately 95% of Oxonica PLC's sales.